Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Prostate Specific Antigen (PSA)”

140 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 140 results

Not applicableActive Not RecruitingNCT00578240
What this trial is testing

Molecular Studies and Clinical Correlations in Human Prostatic Disease

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 5,290
Not applicableStudy completedNCT03087903
What this trial is testing

Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 41
Large-scale testing (Phase 3)UnknownNCT03119857
What this trial is testing

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

Who this might be right for
Prostatic Neoplasms
Göteborg University 349
Not applicableEnded earlyNCT00773773
What this trial is testing

Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer

Who this might be right for
Prostate CancerElevated Prostate Specific Antigen (PSA)
Memorial Sloan Kettering Cancer Center 58
Not applicableStudy completedNCT01763944
What this trial is testing

Carbohydrate Restriction and Prostate Cancer Growth

Who this might be right for
Prostate Cancer
Duke University 83
Testing effectiveness (Phase 2)Study completedNCT00082134
What this trial is testing

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Hormone-refractory Prostate Cancer
Genzyme, a Sanofi Company 40
Testing effectiveness (Phase 2)Study completedNCT01162135
What this trial is testing

Digoxin for Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 16
Not applicableStudy completedNCT02989623
What this trial is testing

Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 25
Not applicableUnknownNCT04773821
What this trial is testing

Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy

Who this might be right for
Prostate Cancer
Assistance Publique - Hôpitaux de Paris 260
Testing effectiveness (Phase 2)Study completedNCT00551525
What this trial is testing

Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 67
Testing effectiveness (Phase 2)Study completedNCT00054574
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Not applicableLooking for participantsNCT07422597
What this trial is testing

Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer

Who this might be right for
Prostate Cancer
Norwegian University of Science and Technology 1,016
Not applicableStudy completedNCT01812902
What this trial is testing

Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy

Who this might be right for
Prostate Cancer
University of Sao Paulo 260
Large-scale testing (Phase 3)Looking for participantsNCT07052214
What this trial is testing

PSMA PET Combined With MRI for the Detection of PCa

Who this might be right for
PCAProstate CancerProstatic Neoplasm+6 more
Telix Pharmaceuticals (Innovations) Pty Limited 338
Testing effectiveness (Phase 2)Study completedNCT00678054
What this trial is testing

Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
University of California, San Francisco 30
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Testing effectiveness (Phase 2)Study completedNCT01220973
What this trial is testing

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Rutgers, The State University of New Jersey 27
Early research (Phase 1)Ended earlyNCT04291664
What this trial is testing

PK and Dose Escalation and Expansion Study of DST-2970

Who this might be right for
Prostate Cancer
DisperSol Technologies, LLC 26
Not applicableEnded earlyNCT02031029
What this trial is testing

Character Traits and Stress in Suspected Prostate Cancer

Who this might be right for
Prostatic Diseases
Helse Stavanger HF 51
Large-scale testing (Phase 3)Study completedNCT00027859
What this trial is testing

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Next Page